ThesisCMS Info Systems: the story is balanced — ATM deployment net additions and renewal rates - bank capex cycles drive new installations, with 15,000-20…
★ Analysts see FY2028 revenue reaching $30.8B — +12.4% growth in a single year.
What Moves the Stock
01ATM deployment net additions and renewal rates - bank capex cycles drive new installations, with 15,000-20,000 annual industry additions expected through 2027
02Cash-in-transit transaction volumes from retail and e-commerce - festive season spikes (Oct-Dec) drive 25-30% quarterly volume increases
03Operating margin expansion from route optimization - every 5% improvement in stops-per-route translates to 100-150bps margin gain
04Brown label ATM profitability - interchange fee changes by NPCI and rural ATM subsidy policy impact this segment's economics
05Contract renewal pricing and competitive bid outcomes - 30-40% of contracts come up for renewal annually
06ATM Managed Services (~65-70% of revenue): Site management, cash replenishment, maintenance for bank-owned ATMs on multi-year contracts
07Cash Management Services (~25-30%): Cash-in-transit, cash processing, vault management for banks, retailers, and e-commerce players
08Brown Label ATM Operations (~5-10%): Company-owned ATMs deployed in rural/semi-urban areas with interchange fee revenue
value - Stock trades at 8.7x EV/EBITDA vs 12-15x for global peers, offering 6.2% FCF yield with 14.4% ROE.
Low direct impact on operations as business is not capital-intensive post initial fleet deployment.
Watch on earnings: India GDP growth rate and private consumption expenditure - drives cash transaction volumes, UPI transaction volume growth and cash-to-GDP ratio trends - monitors digital payment substitution risk, Bank credit growth and ATM capex announcements by top 10 banks - leading indicator for deployment pipeline.
One Sentence Summary:
CMS Info Systems: the story is balanced — atm deployment net additions and renewal rates - bank capex cycles drive new installations, with 15,000-20.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.
